Syndexa Pharmaceuticals
Syndexa Pharmaceuticals develops drugs to treat metabolic diseases.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Syndexa Pharmaceuticals Information
Geographic Data
Address:
City: Watertown
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series b
Raised Last:
$9M
Raised Total:$24M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Syndexa Pharmaceuticals Corp., a Watertown, MA-based biopharmaceutical company developing drugs to treat metabolic diseases. Founded by scientists from Harvard University, and led by President and CEO Teo Uysal, Syndexa is dedicated to the discovery and development of a new generation of small-molecule drugs targeting novel mechanisms for the treatment and prevention of diseases of endoplasmic reticulum (ER) dysfunction which include inflammatory and metabolic diseases and disorders, cardiovascular diseases and neurodegenerative diseases. The company has raised $24.8m of equity capital to date.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2008 | Series B | 1 | $15M |
Yalcin Ayasli Yalcin Ayasli |
1/2012 | Series B | 1 | $8.5M |
MP Healthcare Venture Management MP Healthcare Venture Management |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
